Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Virtual Event

May 27, 2020 10:45 AM - May 29, 2020 3:30 PM

(US Eastern Standard Time)

Fort Washington, PA 19034

DIA/FDA Biostatistics Industry and Regulator Forum

Session 4: The Evolution of MID3 and the Intersection of Biostatistics and Clinical Pharmacology in MID3 Clinical Trials

Session Chair(s)

Jonathan  Haddad, MPH

Jonathan Haddad, MPH

HIV Disease Area Head, Clinical Statistics

GlaxoSmithKline, United States

Lei  Nie, PhD

Lei Nie, PhD

Director, Division of Biometrics IV, Office of Biostatistics, OTS, CDER

FDA, United States

This session will briefly describe the intent and potential benefits of the MID3 approach. We will share current activities to pilot MID3 and to develop guidelines for the use of MID3 in clinical trials. Opportunities for best working practices and collaboration between the biostatistics and clinical pharmacology functions within both the agency and industry will be explored. It is assumed that the audience will have a basic familiarity with MID3.

Learning Objective :

At the conclusion of this session, participants should be able to:

  • Understand joint industry-regulatory authority efforts to pilot and embed MID3 in drug development
  • Understand areas of difficulty requiring special attention related to implementing the MID3 framework
  • Gain insight to where Biostatistics and Clinical Pharmacology functions can collaborate on MID3 trials

Speaker(s)

Lei  Nie, PhD

Model Informed Drug Development (MIDD): Opportunities for Collaboration

Lei Nie, PhD

FDA, United States

Director, Division of Biometrics IV, Office of Biostatistics, OTS, CDER

Hao  Zhu, PhD

Model Informed Drug Development (MIDD): Opportunities for Collaboration

Hao Zhu, PhD

FDA, United States

Division Director, Division of Pharmacometrics, OCP, OTS, CDER

Anubha  Gupta, PhD

Otilimab Case Study

Anubha Gupta, PhD

GSK, United Kingdom

Pharmacometrician/Clinical Pharmacologist

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.